Evidence map›Paper›PMID 40586553›Full record

ArticlemBio2025

Near extinction of the HBV quasispecies driven by the hard selective sweep in chronic hepatitis B.

Daiqiang Lu, Andong He, Guichan Liao, Renyu Zhou, Zichun Cheng, Ka Cheuk Yip, Xiufang Wang, Wei Cao, Jiaojiao Peng, Ruiman Li and 2 more

Abstract read
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Daiqiang Lu *Institute of Molecular and Medical Virology, School of Medicine, Jinan University, Guangzhou, China.ORCID 0009-0002-1085-8134
Andong He *Department of Obstetrics and Gynecology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Guichan Liao *Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Renyu Zhou *Institute of Molecular and Medical Virology, School of Medicine, Jinan University, Guangzhou, China.
Zichun ChengInstitute of Molecular and Medical Virology, School of Medicine, Jinan University, Guangzhou, China.
Ka Cheuk YipDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Xiufang WangDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Wei CaoInstitute of Molecular and Medical Virology, School of Medicine, Jinan University, Guangzhou, China.
Jiaojiao PengInstitute of Molecular and Medical Virology, School of Medicine, Jinan University, Guangzhou, China.
Ruiman LiDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Jinan University, Guangzhou, China.ORCID 0000-0003-1239-7968
Jie PengDepartment of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.ORCID 0000-0003-0928-3134
Feng GaoInstitute of Molecular and Medical Virology, School of Medicine, Jinan University, Guangzhou, China.ORCID 0000-0001-8903-0203

Funding

National Key Research and Development Program of China 2021YFC2301500Program for Guangdong Introducing Innovative and Entrepreneurial Teams 2021ZT09Y552Research Fund for International Scientists of National Natural Science Fund of China 82350710801
6 · The paper itself

Abstract

The viral quasispecies play an important role in pathogenesis. However, little is known about the nature of hepatitis B virus (HBV) quasispecies and its impact on the outcomes of chronic hepatitis B. Here, we characterized the bona fide quasispecies viral populations from 16 chronically infected patients by analyzing the near full-length viral genomes obtained by single genome sequencing. Follow-up plasma samples were collected from six patients after 6 months and from four patients after 3-5 years. We found that the viral population diversity levels were highly variable among these patients, depending on the status of the selection pressure. To further understand the host selection pressure over time, we compared viral sequences from different timepoints in 10 patients and found the hard selective sweep (HSS) at the whole genome level in three of them. This HSS was extremely strong and drove the highly diversified viral quasispecies into a distinct yet homogeneous viral population in each patient after 1-4 years of infection. The identical or nearly identical sequences in the homogeneous viral population indicate that they originate from a single infected source. Predominant and fixed mutations were observed in well-characterized T cell epitopes but not in known epitopes of neutralizing antibodies or N-linked glycosylation sites. Since HSS is strong enough to drive HBV quasispecies into near extinction and frequently occurs in chronic hepatitis B patients, this raises the hope for eliminating HBV from the last single reservoir through enhancing specific T cell immune responses targeting the highly selected homogeneous viruses.IMPORTANCEThe nature of bona fide hepatitis B virus (HBV) quasispecies and its potential impact on the outcomes of chronic hepatitis B are not well understood. Analysis of the high-quality near full-length HBV sequences from chronic hepatitis B patients identifies the strong hard selective sweep that can drive the viral quasispecies into a distinct yet highly homogeneous viral population. The nearly identical viral population suggests that all these viruses are from a single source. Predominant mutations were identified in known T cell epitopes but not in epitopes for neutralizing antibodies, indicating that the hard selective sweep is most likely driven by T cell selection pressure. These findings indicate that enhancement of specific T cell responses during chronic hepatitis B can easily eliminate the highly homogeneous viral population and serve as a promising approach to achieve the goal of a functional cure for chronic hepatitis B.

Indexed as

Hepatitis B, ChronicHepatitis B virusQuasispeciesSelection, GeneticAdultDNA, ViralEpitopes, T-LymphocyteFemaleGenetic VariationGenome, ViralHumansMaleMiddle AgedMutationPhylogenyDNA, ViralEpitopes, T-Lymphocytediversityescapeevolutionhepatitis B virusselection

Identifiers

PMID40586553
PMCPMC12345218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.